ABSTRACT
INTRODUCTION
Cancer is a major challenge all over the world and particularly in Bangladesh where the load is reported to be more than 1,200,000. It has been identified as the 6th cause of mortality in Bangladesh with more than half of the cancer patients dying within five years of diagnosis. This article presents a general overview on targeted therapy and discusses the practicality of a TAT clinical trial in Bangladesh in the context of current cancer management situation in the country.
Monoclonal Antibodies (MAbs)
Monoclonal antibodiesare mono-specific antibodies are produced by clones of identical immune cells. 
Radionuclides
Radionuclides are the major players in radio- α-immunotherapy have shown dramatic superiority over α-immunotherapy, as only a few alpha hits of the nucleus are needed to achieve 63% cell kill (11, 12, 13) .
The unique physical and radiobiologic properties of α-particles, such as short path length and high LET offers the potential for more specific tumor cell killing with less damage to surrounding normal tissues (14, 10) . Thus α-radiation is ideal for killing isolated cancer cells in transit in the vascular and lymphatic systems, as well as in regressing tumors by disruption of tumor capillary networks by targeting and killing tumor capillary endothelial cells. The LET is typically 100 keV/μm, giving a higher probability of causing double strand breaks. The ratio of single strand break/double strand breakα20, is compared to 60 for low LET radiation (15, 16) . Of the many processes involved in destruction of cancer cells, apoptosis and mitotic catastrophe are the two major routes for cell deaths induced by radiation (17, 18) . It also initiates over expression of p53 leading to delays in the G1 phase of the cell cycle (19) .A programmed sequence of events leads to the elimination of cells without releasing cytotoxic substances into the surrounding tissues. Thus apoptosis plays a crucial role in developing and maintaining healthy tissues by eliminating old cells, unnecessary cells, and unhealthy cells (15) .
Currently the α-radionuclides of interest are Bi-212, Bi-213, At-211 and Ac-225.
Targeted α-immunoconjugate
The immunoconjugate is a complex that consist of three separate components: an antibody that binds to a cancer cell antigen with high specificity, an effector molecule that has a high capacity to kill the cancer cell, and a linker that will ensure the effector does not separate from the antibody during transit and will reliably release the Other phase 1 trials for acute myeloid leukemia (AML) was completed at Memorial Sloan Kettering Cancer
Center (25) and for bone metastasis in Norway (26) .
Additional clinical trials included phase I/II trial for post-chemotherapy of AML, systemic trial for metastatic melanoma, glioblastoma and for lymphoma (24, 27, 28) . These investigators also reported positive results without any untoward side effects or toxicities. Tumor regression obtained from systemic TAT was attributed to the killing of tumor capillary endothelial cells. The targeting of tumor capillaries in solid tumors subsequently came to be known as the tumor anti-vascular alpha therapy (TAVAT) and this concept holds promise in the treatment of many solid tumors that over expression antigens against which specific MAbs are available (15).
C595 anti-MUC1
Mucin1 (MUC1) is a highly O-glycosylated, transmembranemucin-type glycoprotein (32) . It is expressed in small amounts on the apical membrane of various types of normal epithelial cells and on the surface of different cell types of hematopoietic origin (33 
Dosing and Effectiveness
Determination permeability for the AIC. Since toxicity and efficacy are the relevant end points for treatment evaluation, the definition of all toxicities at different dose levels is crucial. Though targeted therapy often do not cause significant haematologic toxicity, with higher doses the scenario may be different and there is always the possibility of nephrotoxicity. Dose limiting toxicity of TAT is therefore defined in terms of renal function: GFR and serum creatinine.
Microdosimetry
Microdosimetry is the measurement of the effects of very small amounts of ionizing radiation, especially along the single track of such radiation. It is important not only for radiation protection but also for understanding the mechanisms of radiation action and for assessing the radiation risk (46) . TAT has the advantage of giving therapeutic doses to individual cancer cells and low dose radiation to distant normal cells. However, because of the very short range of alpha radiation, tumor or organ dose is difficult to estimate. Microdosimetry technique can measure the microscopic distribution of energy from different types of radiation. Using the Monte Carlo models for biological dosimetry, the location and form of radionuclides within cells can be used to estimate radiation dose distributions and effects (47) .
Feasibility and Rationale for TAT in Bangladesh
The 
Outcome
The proposed study will bring together the highly The benefits of such agents would include a higher therapeutic index and lower toxicity than conventional therapies and thereby contribute to significantly improved cancer health care in Bangladesh.
Limitations
The main limitation of the TAT trial in Bangladesh will be the complexity and high technological nature of the study as well as the sine qua non for multidisciplinary team work. With regard to dosimetry, it is particularly complicated because of inhomogeneous distribution of the α-particles in tumor and tissues. Therefore the dosimetry technique for α-particles needs to be developed in Bangladesh through state-of-the-art biological dosimetrymodels.
Patients will require repeat laboratory testing and biopsies of the tumours which may be inconvenient. Explaining the circumstances of the tests with compassion, care and understanding towards the patient may make these unpleasant situations somewhat acceptable to the patient. Combined with other therapies, including chemotherapy, signaling pathway inhibitors and even targeted β-emitting radionuclides, TAT is likely to improve survival" (15) .
